METEORIC-HF

A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects with Heart Failure with Reduced Ejection Fraction and Decreased Exercise Tolerance

Stadium
klaar
Middel
Omecamtiv Mecarbil
Populatie
Hartfalen
Fase
III
First Patient In
9 juli 2020
Last Patient In
8 juni 2021
Last Patient Last Visit
30 november 2021

National Lead

prof. dr. A. Voors

Cardioloog

Contact Kantoor

F.C.H. Bindels

Portfoliomanager

De pagina is verlopen.